Purchase Order 75N92025P00404
Award Date
9/24/25
Potential Completion Date
9/23/26
Potential Value
$653K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Vector Biomed Inc.
Ultimate Awardee
Not listed
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
North Potomac, MD 20878, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price contract for $803,500.00 was awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS), to Vector Biomed Inc. for the production and stability testing of clinical grade lentiviral vector. The services include manufacturing a minimum of 50mg of GMP/clinical grade transfer plasmid and 400ml of concentrated, GMP grade lentiviral vector, as well as performing stability testing...
<p>The National Heart Lung and Blood Institute (NHLBI) awarded a $611,500.00 firm fixed-price purchase order contract to Vector Biomed Inc. for the production of a lentiviral vector, CX170. This contract, which does not have a set-aside designation, has a completion date of September 2, 2027. The place of performance is in NO POTOMAC, MD 20878, USA.</p>
This firm fixed-price purchase order contract was awarded by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Vector Biosystems, Inc. (doing business as Vector Biolabs), a minority-owned and small disadvantaged for-profit biotechnology company. The $10,870.00 contract is for the delivery of adeno-associated viruses (AAVs) to express mitochondrial and cytosolic-targeted reactive oxygen species (ROS) sensitive proteins. This will support...
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) awarded a purchase order contract valued at one hundred twenty thousand six hundred dollars ($120,600) to Vector Biomed Inc. The contract is to obtain preclinical grade lentiviral vectors in support of NCI's Pediatric Oncology Branch investigational new drug enabling studies and demonstration of clinical-grade vector production feasibility. Services include receipt confirmation...
This firm-fixed-price purchase order contract was awarded by the National Center for Advancing Translational Sciences (NCATS), part of the U.S. Department of Health and Human Services, to Vector Biosystems, Inc. (doing business as Vector Biolabs), a for-profit biotechnology company that provides gene delivery products and services. The $16,120 contract is for the delivery of an AAV viral vector with an EF1a promotor expressing a green fluorescent protein. This contract supports NCATS' biomedical...
This firm-fixed price purchase order contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Expression Manufacturing LLC, a for-profit limited liability company, to provide 250 ml of concentrated lentiviral vector and conduct stability testing. The contract, valued at $648,968.00, has an ultimate completion date of August 31, 2029. This sole-source procurement was originally...
Vector Biosystems, Inc., doing business as Vector Biolabs, has been awarded a firm fixed-price purchase order valued at three thousand six hundred twenty-five U.S. dollars ($3,625) by the National Institutes of Health's National Institute on Alcohol Abuse and Alcoholism (NIAAA). The contract term is from November 24, 2017 through November 23, 2018 for Vector Biolabs to provide unspecified products or services to NIAAA in support of its biomedical research programs. Place of performance will be...
This federal contract award was made by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the U.S. Department of Health and Human Services (HHS), to Vector Biosystems, Inc. (doing business as Vector Biolabs), a minority-owned, self-certified small disadvantaged biotechnology company located in Malvern, Pennsylvania. The $6,230 firm-fixed-price contract was awarded on March 12, 2010 for the delivery of a KI vector constructed with interleukin-17A (IL-17A)....
The National Institute of Neurological Disorders and Stroke, a component of the National Institutes of Health, awarded a $15,238 firm fixed price purchase order to Vectorbuilder Inc. for AAV8 large-scale 10 and ultra-purification packaging services. The contract has an ultimate completion date of August 26, 2025. Vectorbuilder is a specialized biotechnology company that provides gene delivery and molecular biology services to various federal agencies, including the Department of Veterans Affairs...
Vectorbuilder Inc. has been awarded a firm fixed price purchase order in the amount of $11,437 by the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases to provide custom adeno-associated virus packaging. No set-aside designation was applied to this procurement. Per the award description, Vectorbuilder will deliver molecular cloning services to support the NIDDK's biomedical research efforts. As a global leader in gene delivery technologies,...